The Interaction of Acute‐Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial

Author:

Black Dennis M.1ORCID,Reid Ian R.2ORCID,Napoli Nicola34ORCID,Ewing Susan K.1ORCID,Shiraki Masataka5ORCID,Nakamura Toshitaka6,Takeuchi Yasuhiro78,Schafer Anne L.1910ORCID,Kim Tiffany Y.910ORCID,Cauley Jane A.11ORCID

Affiliation:

1. Department of Epidemiology and Biostatistics University of California, San Francisco San Francisco CA USA

2. Department of Medicine University of Auckland Auckland New Zealand

3. Division of Endocrinology and Diabetes University Campus Bio‐Medico di Roma Rome Italy

4. Department of Internal Medicine, Division of Bone and Mineral Diseases, Musculoskeletal Research Center Washington University School of Medicine St. Louis MO USA

5. Research Institute and Practice for Involutional Diseases Nagano Japan

6. National Center for Global Health and Medicine Tokyo Japan

7. Toranomon Hospital Endocrine Center Tokyo Japan

8. Okinaka Memorial Institute for Medical Research Tokyo Japan

9. Department of Medicine University of California, San Francisco San Francisco CA USA

10. Endocrine Research Unit San Francisco Veterans Affairs Health Care System San Francisco CA USA

11. Department of Epidemiology Graduate School of Public Health, University of Pittsburgh Pittsburgh PA USA

Funder

Asahi Kasei Pharma Corporation

Novartis Pharma

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3